ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 360 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,004 | -19.0% | 265,548 | -6.8% | 0.00% | -33.3% |
| Q1 2024 | $8,651 | -23.4% | 284,889 | -29.2% | 0.00% | -25.0% |
| Q4 2023 | $11,296 | -68.3% | 402,118 | -69.4% | 0.00% | -81.8% |
| Q3 2023 | $35,664 | +5.1% | 1,314,079 | +19.1% | 0.02% | +4.8% |
| Q2 2023 | $33,928 | +117.3% | 1,103,665 | +154.6% | 0.02% | +200.0% |
| Q1 2023 | $15,617 | -1.8% | 433,461 | +7.8% | 0.01% | 0.0% |
| Q4 2022 | $15,896 | -99.8% | 402,190 | +82.2% | 0.01% | -30.0% |
| Q3 2022 | $8,868,000 | +0.1% | 220,693 | +4.7% | 0.01% | +100.0% |
| Q2 2022 | $8,862,000 | +22.6% | 210,779 | +13.6% | 0.01% | -16.7% |
| Q1 2022 | $7,231,000 | – | 185,560 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |